Qualigen Therapeutics News

Qualigen Therapeutics | 424B3: Prospectus

May 4 01:52

Qualigen Therapeutics | EFFECT: Others

May 3 18:06

Qualigen Therapeutics | 424B3: Prospectus

Sep 30, 2023 04:30

Qualigen Therapeutics | EFFECT: Others

Sep 8, 2023 12:15

Qualigen Therapeutics | EFFECT: Others

Jan 6, 2023 13:15

Qualigen Therapeutics | EFFECT: Others

Aug 8, 2022 12:15

Qualigen Therapeutics | EFFECT: Others

Jun 30, 2022 12:15

Qualigen Therapeutics | 424B5: Prospectus

Dec 2, 2021 03:28

Qualigen Therapeutics | 424B5: Prospectus

Dec 19, 2020 02:26

Qualigen Therapeutics | 424B5: Prospectus

Oct 3, 2020 04:24

Qualigen Therapeutics | 424B5: Prospectus

Aug 4, 2020 18:16

Qualigen Therapeutics | 424B5: Prospectus

Jul 11, 2020 02:35

Qualigen Therapeutics | 424B5: Prospectus

May 28, 2020 00:57

Qualigen Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 20, 2020 04:24

Qualigen Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 15, 2020 05:10

Qualigen Therapeutics | 424B3: Prospectus

May 14, 2020 21:50

Qualigen Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 11, 2020 20:02

Qualigen Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 9, 2020 04:05

Qualigen Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 6, 2020 21:22

Qualigen Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 5, 2020 18:13